Establishment of the strategic prophylaxis for the deep vein thrombosis by the remote ischemic preconditioning.
Not Applicable
- Conditions
- deep vein thrombosis
- Registration Number
- JPRN-UMIN000013662
- Lead Sponsor
- Toyama University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Anticoagulant therapy Heparin bridge Neuropathy of the superior limb Brachial edema RA Steroid therapy Ischemic heart disease Obesity BMI>30
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Soluble fibrin monomer complex level D-Dimer level FDP level Plasminogen activity level
- Secondary Outcome Measures
Name Time Method F-kappa B level Plasma cytocine level (IL6, IL-1beta, IL-10, TNF-alpha) Safety (measured by incidence of adverse events and discontinuation rate due to adverse events)